Zobrazeno 1 - 2
of 2
pro vyhledávání: '"David G. Scholten"'
Autor:
Sandra M. Axiak‐Bechtel, Stacey B. Leach, David G. Scholten, Jessica R. Newton‐Northup, Brendan J. Johnson, H. E. Durham, Kenneth A. Gruber, Michael F. Callahan
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)
Abstract The melanocortin‐4 receptor (MC4R) antagonistic peptide TCMCB07 was developed for the treatment of cachexia. The objectives of this study were to examine pharmacokinetics and safety of TCMCB07 administered subcutaneously to healthy dogs. D
Externí odkaz:
https://doaj.org/article/a92e2723027b41b2b1954a4acdd0347b
Autor:
David G Scholten, Michael F. Callahan, Kenneth A. Gruber, H E Durham, Jessica Newton-Northup, Stacey B. Leach, Brendan J. Johnson, Sandra M. Axiak-Bechtel
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives
The melanocortin‐4 receptor (MC4R) antagonistic peptide TCMCB07 was developed for the treatment of cachexia. The objectives of this study were to examine pharmacokinetics and safety of TCMCB07 administered subcutaneously to healthy dogs. Dogs were